Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2008
12/11/2008CA2691617A1 Reduction of off-target rna interference toxicity
12/11/2008CA2691446A1 Pro-drugs of nsaias with very high skin and membranes penetration rates and their new medicinal uses
12/11/2008CA2691039A1 Il-18 and protein kinase r inhibition for the treatment of copd
12/11/2008CA2690856A1 Oxadiazole derivatives and their use as metabotropic glutamate receptor potentiators - 842
12/11/2008CA2690848A1 Estrogen receptor-related receptor gamma (erry) in bone and cartilage formation and methods and compositions relating to same
12/11/2008CA2690725A1 Targeting of sall4 for the treatment and diagnosis of proliferative disorders associated with myelodysplastic syndrome (mds)
12/11/2008CA2690292A1 Prolinamide-tetrazole derivatives as nk3 receptor antagonists
12/11/2008CA2690288A1 Quinoxaline derivatives as inhibitors of the tyrosine kinase activity of janus kinases
12/11/2008CA2690151A1 Enteric coated, soluble creatine and polyethylene glycol composition for enhanced skeletal uptake of oral creatine
12/11/2008CA2690091A1 New disubstituted phenylpyrrolidines as modulators of cortical catecholaminergic neurotransmission
12/11/2008CA2690089A1 Methods and compositions for delivery of medicaments to the lungs
12/11/2008CA2690013A1 Telomerase activating compounds and methods of use thereof
12/11/2008CA2690004A1 Tri-aryl compounds and compositions comprising the same
12/11/2008CA2690001A1 Substituted benzoylamino-indan-2-carboxylic acids and related compounds
12/11/2008CA2689985A1 Di(hetero)arylcyclohexane derivatives, their preparation, their use and pharmaceutical compositions comprising them
12/11/2008CA2689914A1 Methods and compositions for treating recurrent cancer
12/11/2008CA2689692A1 New disubstituted phenylpyrrolidines as modulators of cortical catecholaminergic neurotransmission
12/11/2008CA2689633A1 Use of ranolazine for elevated brain-type natriuretic peptide
12/11/2008CA2689612A1 Triazolo [1, 5-a] quinolines as adenosine a3 receptor ligands
12/11/2008CA2689581A1 Anti -inflammatory substituted cyclobutenedione compounds
12/11/2008CA2689560A1 Prolinamide derivatives as nk3 antagonists
12/11/2008CA2689554A1 2-oxo-3-benzylbenzoxazol-2-one derivatives and related compounds as met kinase inhibitors for the treatment of tumours
12/11/2008CA2689514A1 Heterobicyclic compounds as kinase inhibitors
12/11/2008CA2689374A1 Pyrimidodiazepinone derivative
12/11/2008CA2689337A1 Crystalline form b of olmesartan medoxomil
12/11/2008CA2689310A1 Protein kinase-binding nucleosides and associated methods
12/11/2008CA2689282A1 Benzamide mglur5 positive allosteric modulators and methods of making and using same
12/11/2008CA2689242A1 Agent and method for treatment of cancer
12/11/2008CA2689148A1 Tricyclic inhibitors of fatty acid amide hydrolase
12/11/2008CA2688621A1 Macrocycles and their uses
12/11/2008CA2688616A1 Selective inhibitors for cyclin-dependent kinases
12/11/2008CA2688594A1 Aryloxazole, aryloxadiazole and benzimidazole derivatives
12/11/2008CA2688547A1 Aromatic and heteroaromatic compounds useful in treating iron disorders
12/11/2008CA2688493A1 Phenyl substituted cycloalkylamines as monoamine reuptake inhibitors
12/11/2008CA2688463A1 Process for the preparation of rizatriptan
12/11/2008CA2688439A1 Treatment of age-related macular degeneration
12/11/2008CA2688415A1 Nucleic acid nanoparticles and uses therefor
12/11/2008CA2688412A1 Metal complexes incorporated within biodegradable nanoparticles and their use
12/11/2008CA2688136A1 Pyrrole-2-carboxamide derivatives as glucokinase activators, their process and pharmaceutical application
12/11/2008CA2688079A1 5beta, 14beta-androstane derivatives useful for the treatment of restenosis after angioplastic or endoartherectomy and diseases due to organ fibrosis
12/11/2008CA2688035A1 Therapeutic treatment for metabolic syndrome, type 2 diabetes, obesity, or prediabetes
12/11/2008CA2687918A1 Piperidine/piperazine derivatives
12/11/2008CA2687912A1 Piperidine/piperazine derivatives
12/11/2008CA2687754A1 Piperidine/piperazine derivatives
12/11/2008CA2687731A1 Novel agent for salting out active principles in dressings containing at least one fatty substance
12/11/2008CA2687730A1 Novel active ingredient in cicatrization and use thereof
12/11/2008CA2687274A1 Use of hdac inhibitors for the treatment of bone destruction
12/11/2008CA2687243A1 Piperidine/piperazine derivatives
12/11/2008CA2687230A1 Cyclopropyl pyrrolidine orexin receptor antagonists
12/11/2008CA2686558A1 Pharmaceutical or cosmetic preparations for topical and/or parenteral application, preparation methods thereof and use of same
12/11/2008CA2686556A1 Pharmaceutical or cosmetic preparations for topical and/or parenteral application, methods for the preparation thereof, and uses thereof
12/11/2008CA2685482A1 Dermatological and cosmetic depigmenting compositions, methods for the preparation thereof and uses thereof
12/11/2008CA2682326A1 Neramexane for the treatment of nystagmus
12/11/2008CA2680842A1 N-acetyl mannosamine as a therapeutic agent
12/11/2008CA2600147A1 Combination for treatment of diabetes mellitus
12/10/2008EP2000540A2 Triprenyl phenol compound, process for production of triprenyl phenol compound, and thrombolysis enhancer
12/10/2008EP2000479A1 Genetic Sequences and Proteins Related to Alzheimer's Disease, and Uses Therefor
12/10/2008EP2000478A1 Biologically active peptide and agent containing the same
12/10/2008EP2000473A2 Trehalose compound and pharmaceutical comprising the compound
12/10/2008EP2000472A1 Rapamycin Analogs Containing an Antioxidant Moiety
12/10/2008EP2000471A1 Rapamycin Analogs Containing an Antioxidant Moiety
12/10/2008EP2000470A1 Rapamycin Analogs Containing an Antioxidant Moiety
12/10/2008EP2000469A2 Acylaminopiperidine compound
12/10/2008EP2000468A1 Esomeprazole salts and processes for preparation thereof
12/10/2008EP2000467A2 Hydrate for medical purposes
12/10/2008EP2000465A1 Triazolone derivative
12/10/2008EP2000462A2 Non-imidazole alkylamines as histamine H3-receptor ligands and their therapeutic applications
12/10/2008EP2000461A1 Crystalline forms of atorvastatin
12/10/2008EP2000152A2 Solid preparation having improved solubility
12/10/2008EP2000149A1 Chimeric anti-CD20 antibody
12/10/2008EP2000144A1 Prophylactic and therapeutic treatment of infectious, autoimmune and allergic diseases with mono-and disaccharide-based compounds
12/10/2008EP2000143A2 Transdermal gel compositions containing testosterone and their use for the treatment of fibromyalgia, chronic fatigue syndrome, muscle pain or decreased libido
12/10/2008EP2000142A1 Method for treating severe heart failure and medicament therefor
12/10/2008EP2000141A1 Methods for preparing crystalline quetiapine hemifumarate
12/10/2008EP2000140A1 Use of derivatives of 3-oxo-2,3-dihydro-5H-thiazolo[3,2-a]pyrimidine or of 3-oxo-2,3-dihydro-5H-imidazolo[3,2-a]pyrimidine for the preparation of pharmaceutical compositions intended for the treatment of cancer
12/10/2008EP2000139A1 Stabilized amorphous forms of imatinib mesylate
12/10/2008EP2000137A2 Triglyceride-lowering agent and hyperinsulinism-ameliorating agent
12/10/2008EP2000136A2 Compositions and methods for the treatment of inflammatory diseases using topoisomerase inhibitors
12/10/2008EP2000134A1 Use of a substance for the improvement of pns lesions
12/10/2008EP2000133A2 Pharmaceutical composition containing fenofibrate and method for the preparation thereof
12/10/2008EP1999626A2 Methods, compositions, and kits for the treatment of musculoskeletal disorders and symptoms associated therewith
12/10/2008EP1999267A2 Methods of expressing gam-negative glycosaminoglycosaminoglycan synthase genes in gram-positive hosts
12/10/2008EP1999260A2 Dsrna compositions and methods for treating hpv infection
12/10/2008EP1999139A2 Betulonic acid esters and betulinic acid polyalkylene-glycol derivatives for the treatment of viral infection and cancer
12/10/2008EP1999136A1 Peptidomimetic inhibitors of psma,compounds comprising them, and methods of use
12/10/2008EP1999135A2 Kinase inhibitors
12/10/2008EP1999132A1 Azolopyrimidines as inhibitors of cannabinoid 1 activity
12/10/2008EP1999131A2 Bicyclo-pyrazoles active as kinase inhibitors
12/10/2008EP1999130A1 Pyridopyrimidine derivatives and their use as pde4 inhibitors
12/10/2008EP1999128A1 Tetomilast polymorphs
12/10/2008EP1999127A1 Phthalazinone pyrazole derivatives, their manufacture and use as pharmaceutical agents
12/10/2008EP1999126A1 Cyclic-alkylaminederivatives as inhibitors of the interaction between mdm2 and p53
12/10/2008EP1999124A1 Glycosidase inhibitors and methods of synthesizing same
12/10/2008EP1999123A1 Substituted chromanol derivatives and their use
12/10/2008EP1999121A1 Novel tetralins as 5-ht6 modulators
12/10/2008EP1999120A1 Benzothiazoles having histamine h3 receptor activity
12/10/2008EP1999119A2 Novel acetyl-coa carboxylase (acc) inhibitors and their use in diabetes, obesity and metabolic syndrome
12/10/2008EP1999117A2 Renin inhibitors
12/10/2008EP1999113A1 Substituted 1-amino-4-phenyl-dihydroisoquinolines, method for the production thereof, use thereof as a medicament, and medicaments containing them
12/10/2008EP1999112A2 Substituted 2-amino-4-phenyl-d hydroquinolines, method for the production thereof, use thereof as medicaments, and medicaments containing them
1 ... 2958 2959 2960 2961 2962 2963 2964 2965 2966 2967 2968 2969 2970 2971 2972 2973 2974 2975 2976 2977 2978 ... 7860